Alireza Sharifi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Alireza Sharifi has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Afshar Etemadi-Aleagha
Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Ahmad Ghashghaee
Student Research Committee, Qazvin University of Medical Sciences, Qazvin, Iran
1 shared publication - Ahmad Hormati
Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Alireza Teymouri
Department of Physical Medicine and Rehabilitation, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Fatemeh Mirashrafi
Otorhinolaryngology Head and Neck Surgery Department, Otorhinolaryngology Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Fatemeh Pashazadeh Kan
Student Research Committee, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 1 March 2024
- Published by Brieflands in International Journal of Infection
- Vol. 10 (2)
Impact of COVID-19 Pandemic on Otolaryngologic Surgeries in Iranian Pediatrics
Background: There is no study about the evaluation of incidence rates of tonsillectomy, adenoidectomy, and ear surgeries before and during the coronavirus disease 2019 (COVID-19) pandemic and the impact of pandemic peaks on the incidence rates of these operations in the world, particularly in Iran. Objectives: This study aimed to evaluate the impact of the COVID-19 pandemic on the number of most common otolaryngologic operations in the Iranian pediatric population. Methods: This retrospective study was performed in a referral hospital. The data of target patients over the period of March 21, 2018, to November 22, 2021, were collected. The number of surgeries at the period of any peak plus before and during the COVID-19 pandemic was compared. Results: A total of 6 290 patients from the Health Information System of Amir A’lam hospital, Tehran, Iran, were enrolled. In this study, 52.9% and 46.5% of the patients were male and female, respectively. There were 3 main types of surgeries, such as adenoidectomy, tonsillectomy, and ear surgeries, with mean ± standard deviation (SD) age of 10.20 ± 9.4, 11.45 ± 10.8, and 44.19 ± 14.6 years, respectively. There was a significant difference in terms of the total number of operations between before (n = 5070) and during the COVID-19 pandemic (n = 1220) (P < 0.001). The amount of this difference was much greater in tonsillectomy (n = 3736 vs. n = 546) and adenoidectomy (n = 134 vs. n = 21) than in ear surgeries (n = 1200 vs. n = 653). Conclusions: The COVID-19 pandemic significantly reduced the number of most common otolaryngologic surgeries in the Iranian pediatric population. The reason is that the restrictions during the pandemic might have a potential effect on reducing the transmission of tonsil-adenoid gland infection.
- 1 March 2024
- Published by Brieflands in International Journal of Infection
- Vol. 10 (2)
Open AccessImpact of COVID-19 Pandemic on Otolaryngologic Surgeries in Iranian Pediatrics
Background: There is no study about the evaluation of incidence rates of tonsillectomy, adenoidectomy, and ear surgeries before and during the coronavirus disease 2019 (COVID-19) pandemic and the impact of pandemic peaks on the incidence rates of these operations in the world, particularly in Iran. Objectives: This study aimed to evaluate the impact of the COVID-19 pandemic on the number of most common otolaryngologic operations in the Iranian pediatric population. Methods: This retrospective study was performed in a referral hospital. The data of target patients over the period of March 21, 2018, to November 22, 2021, were collected. The number of surgeries at the period of any peak plus before and during the COVID-19 pandemic was compared. Results: A total of 6 290 patients from the Health Information System of Amir A’lam hospital, Tehran, Iran, were enrolled. In this study, 52.9% and 46.5% of the patients were male and female, respectively. There were 3 main types of surgeries, such as adenoidectomy, tonsillectomy, and ear surgeries, with mean ± standard deviation (SD) age of 10.20 ± 9.4, 11.45 ± 10.8, and 44.19 ± 14.6 years, respectively. There was a significant difference in terms of the total number of operations between before (n = 5070) and during the COVID-19 pandemic (n = 1220) (P < 0.001). The amount of this difference was much greater in tonsillectomy (n = 3736 vs. n = 546) and adenoidectomy (n = 134 vs. n = 21) than in ear surgeries (n = 1200 vs. n = 653). Conclusions: The COVID-19 pandemic significantly reduced the number of most common otolaryngologic surgeries in the Iranian pediatric population. The reason is that the restrictions during the pandemic might have a potential effect on reducing the transmission of tonsil-adenoid gland infection.
- Open Access
- 1 January 2024
- Published by Apex Publishing in WORLD JOURNAL OF PLASTIC SURGERY
- Vol. 13 (1) , 32-36
The Safety and Outcomes of Simultaneous Open Rhinoplasty, Alar Reduction, and Upper Lip-Lift through One Surgery
Background: The safety and outcomes of performing a simultaneous Alar reduction, Lip lift, and Open rhinoplasty Surgery (ALOS) through independent incisions have not been reported in any study, therefore, we aimed to evaluate the safety and outcomes of this combination procedure. Methods: This retrospective review study was conducted on all ...
- 1 January 2024
- Published by Apex Publishing in WORLD JOURNAL OF PLASTIC SURGERY
- Vol. 13 (1) , 32-36
Open AccessThe Safety and Outcomes of Simultaneous Open Rhinoplasty, Alar Reduction, and Upper Lip-Lift through One Surgery
Background: The safety and outcomes of performing a simultaneous Alar reduction, Lip lift, and Open rhinoplasty Surgery (ALOS) through independent incisions have not been reported in any study, therefore, we aimed to evaluate the safety and outcomes of this combination procedure. Methods: This retrospective review study was conducted on all ...
- 22 June 2023
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 280 (10) , 4677-4685
Uvulopalatopharyngoplasty with and without modified thyrohyoid suspension for obstructive sleep apnea treatment: a randomized clinical trial
Purpose This study aims to compare the efficacy of Uvulopalatopharyngoplasty + Tongue Base Radiofrequency (TB-RF) and Uvulopalatopharyngoplasty + modified thyrohyoid suspension techniques + TB-RF which aimed to suspend base of tongue muscles anteriorly toward thyroid cartilage. Methods This randomized controlled trial study was conducted on 48 cases of confirmed OSA between Jan, 2019 and Aug, 2022. We divided patients into two groups. One group underwent Uvulopalatopharyngoplasty + modified thyrohyoid suspension + TB-RF technique, and another one underwent Uvulopalatopharyngoplasty + TB-RF. Then, Apnea–Hypopnea Index (AHI), mean and lowest O2 saturation, Drug-Induced Sleep Endoscopy (DISE), Epworth Sleepiness Scale (ESS), Digit Symbol Substitution Test (DSST), Stanford Subjective Snoring Scale (SSSS), and T90 indexes were evaluated before and after each surgery. Results The mean ± SD age was 39.4 ± 11.17 years. Of the 48 patients, 79.1% (n = 33) were male and 20.9% (n = 15) were female. AHI and SSSS in the Uvulopalatopharyngoplasty + modified thyrohyoid suspension group were significantly better than Uvulopalatopharyngoplasty group (P-value; 0.010). Though, there was no significant difference in terms of mean saturation, lowest desaturation, ESS, DSST, and T90 scores. The success rate in the Uvulopalatopharyngoplasty + modified thyrohyoid suspension and Uvulopalatopharyngoplasty groups, according to the Sher criteria: a minimum of 50% reduction with a final AHI less than 20, were 75% (18/24) and 41.7% (10/24), respectively. It was significantly higher in the Uvulopalatopharyngoplasty + modified thyrohyoid suspension group (P-value: 0.021). Conclusion The addition of modified thyrohyoid suspension technique to Uvulopalatopharyngoplasty have better surgical outcomes and more success rate than Uvulopalatopharyngoplasty in OSA patients. Trial registration: IRCT: IRCT20190602043791N2. https://en.irct.ir/trial/53365.
- 22 June 2023
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 280 (10) , 4677-4685
Uvulopalatopharyngoplasty with and without modified thyrohyoid suspension for obstructive sleep apnea treatment: a randomized clinical trial
Purpose This study aims to compare the efficacy of Uvulopalatopharyngoplasty + Tongue Base Radiofrequency (TB-RF) and Uvulopalatopharyngoplasty + modified thyrohyoid suspension techniques + TB-RF which aimed to suspend base of tongue muscles anteriorly toward thyroid cartilage. Methods This randomized controlled trial study was conducted on 48 cases of confirmed OSA between Jan, 2019 and Aug, 2022. We divided patients into two groups. One group underwent Uvulopalatopharyngoplasty + modified thyrohyoid suspension + TB-RF technique, and another one underwent Uvulopalatopharyngoplasty + TB-RF. Then, Apnea–Hypopnea Index (AHI), mean and lowest O2 saturation, Drug-Induced Sleep Endoscopy (DISE), Epworth Sleepiness Scale (ESS), Digit Symbol Substitution Test (DSST), Stanford Subjective Snoring Scale (SSSS), and T90 indexes were evaluated before and after each surgery. Results The mean ± SD age was 39.4 ± 11.17 years. Of the 48 patients, 79.1% (n = 33) were male and 20.9% (n = 15) were female. AHI and SSSS in the Uvulopalatopharyngoplasty + modified thyrohyoid suspension group were significantly better than Uvulopalatopharyngoplasty group (P-value; 0.010). Though, there was no significant difference in terms of mean saturation, lowest desaturation, ESS, DSST, and T90 scores. The success rate in the Uvulopalatopharyngoplasty + modified thyrohyoid suspension and Uvulopalatopharyngoplasty groups, according to the Sher criteria: a minimum of 50% reduction with a final AHI less than 20, were 75% (18/24) and 41.7% (10/24), respectively. It was significantly higher in the Uvulopalatopharyngoplasty + modified thyrohyoid suspension group (P-value: 0.021). Conclusion The addition of modified thyrohyoid suspension technique to Uvulopalatopharyngoplasty have better surgical outcomes and more success rate than Uvulopalatopharyngoplasty in OSA patients. Trial registration: IRCT: IRCT20190602043791N2. https://en.irct.ir/trial/53365.
- Open Access
- 23 May 2022
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 15 (3)
Comparing Diagnostic Accuracy of the fliD Gene and the glmM Gene in Helicobacter pylori
Background: Helicobacter pylori is one of the most common human bacterial infections, accounting for the infection of half of the world's population. The polymerase chain reaction (PCR) has high specificity and sensitivity in diagnosing this bacterial infection. Objectives: The present study aimed to compare the sensitivity and specificity of the fliD gene and the most widely used glmM gene in the PCR technique. Methods: The research population encompassed patients with indications for upper endoscopy. This cross-sectional study compared the sensitivity and specificity of a proposed gene (fliD) with the most widely used glmM gene to detect the H. pylori infection in tissue samples. Results: The participants encompassed ninety-nine participants aged above 18 years. Their median age was 45.92 ± 13.63 years. The most common complaints of the patients were epigastric pain and heartburn. Our described gold standard detected 61.6% and 38.4% as positive and negative, respectively. The sensitivity and specificity were 72.1% and 100.0% for the routine PCR (glmM gene) and 80.3% and 94.7% for the proposed PCR (fliD gene). Conclusions: Different genes have been used to detect H. pylori in PCR. The glmM gene is easily used to diagnose the H. pylori infection; however, according to the present findings, the fliD gene has higher sensitivity than the glmM gene. Accordingly, the former can be used as a screening gene for the H. pylori infection in the PCR technique.
- 23 May 2022
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 15 (3)
Open AccessComparing Diagnostic Accuracy of the fliD Gene and the glmM Gene in Helicobacter pylori
Background: Helicobacter pylori is one of the most common human bacterial infections, accounting for the infection of half of the world's population. The polymerase chain reaction (PCR) has high specificity and sensitivity in diagnosing this bacterial infection. Objectives: The present study aimed to compare the sensitivity and specificity of the fliD gene and the most widely used glmM gene in the PCR technique. Methods: The research population encompassed patients with indications for upper endoscopy. This cross-sectional study compared the sensitivity and specificity of a proposed gene (fliD) with the most widely used glmM gene to detect the H. pylori infection in tissue samples. Results: The participants encompassed ninety-nine participants aged above 18 years. Their median age was 45.92 ± 13.63 years. The most common complaints of the patients were epigastric pain and heartburn. Our described gold standard detected 61.6% and 38.4% as positive and negative, respectively. The sensitivity and specificity were 72.1% and 100.0% for the routine PCR (glmM gene) and 80.3% and 94.7% for the proposed PCR (fliD gene). Conclusions: Different genes have been used to detect H. pylori in PCR. The glmM gene is easily used to diagnose the H. pylori infection; however, according to the present findings, the fliD gene has higher sensitivity than the glmM gene. Accordingly, the former can be used as a screening gene for the H. pylori infection in the PCR technique.
- 22 July 2021
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 13 (4) , 365-373
Hemodialysis and peritoneal dialysis—health-related quality of life: systematic review plus meta-analysis
Background Patients with end-stage renal disease undergoing haemodialysis experience a variety of stressors leading to decreased level of quality of life (QoL). Thus, in this study, we aimed to review the current literature and identify factors affecting the health-related QoL (HRQoL) in these patients. Methods A total of 147 studies were extracted from databases of Web of Science, PubMed, Scopus, Google Scholar, and Embase published between January 2000 and December 2020. Data were analysed using R software and results were reported with reference to Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards. Results A total of 623 728 patients undergoing dialysis participated in 147 studies in which QoL was assessed by means of two valid questionnaires, including Short-Form 36 (SF-36) and Kidney Disease Quality of Life (KDQOL)-short form V.1.3. Total HRQoL score for patients undergoing dialysis measured by KDQOL was 64.25 (95% CI 55.67 to 72.82). Based on SF-36, the mean score of mental health items was higher than the mean score of physical health condition. Furthermore, meta-regression based on the geographical place of residence revealed that the highest QoL in patients was observed in Japan, 66.96 (95% CI 63.65 to 70.28) and Brazil, 58.03 (95% CI 53.45 to 62.6). Conclusion Studies conducted on HRQoL among patients undergoing dialysis recommend useful strategies to clinicians, letting them assess patients’ QoL in terms of a wide range of physical, mental and environmental aspects.
- 22 July 2021
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 13 (4) , 365-373
Hemodialysis and peritoneal dialysis—health-related quality of life: systematic review plus meta-analysis
Background Patients with end-stage renal disease undergoing haemodialysis experience a variety of stressors leading to decreased level of quality of life (QoL). Thus, in this study, we aimed to review the current literature and identify factors affecting the health-related QoL (HRQoL) in these patients. Methods A total of 147 studies were extracted from databases of Web of Science, PubMed, Scopus, Google Scholar, and Embase published between January 2000 and December 2020. Data were analysed using R software and results were reported with reference to Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards. Results A total of 623 728 patients undergoing dialysis participated in 147 studies in which QoL was assessed by means of two valid questionnaires, including Short-Form 36 (SF-36) and Kidney Disease Quality of Life (KDQOL)-short form V.1.3. Total HRQoL score for patients undergoing dialysis measured by KDQOL was 64.25 (95% CI 55.67 to 72.82). Based on SF-36, the mean score of mental health items was higher than the mean score of physical health condition. Furthermore, meta-regression based on the geographical place of residence revealed that the highest QoL in patients was observed in Japan, 66.96 (95% CI 63.65 to 70.28) and Brazil, 58.03 (95% CI 53.45 to 62.6). Conclusion Studies conducted on HRQoL among patients undergoing dialysis recommend useful strategies to clinicians, letting them assess patients’ QoL in terms of a wide range of physical, mental and environmental aspects.